Imagen de Portada

Multidisciplinary meetings for lower urinary tract symptoms and benign prostate hyperplasia

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Emilien Seizilles de Mazancourt, Nadia Abid, Gaele Pagnoux, Olivier Rouvière, Ricardo Codas Duarte, Alain Ruffion, Hakim Fassi Fehri
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	BJUI Compass
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The impact of vaporization on adenoma weight in benign prostatic hyperplasia surgery
por: André B. Silva, et al.
Publicado: (2026)

Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
por: Mathew Thakur, et al.
Publicado: (2024)

Association of erectile dysfunction and male lower urinary tract symptoms in a Japanese cross‐sectional survey
por: Katsuya Yamaguchi, et al.
Publicado: (2026)

Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
por: Ansh Bhatia, et al.
Publicado: (2024)

WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
por: Mohamad Baker Berjaoui, et al.
Publicado: (2024)

Malignant upper urinary tract obstruction in cancer patients: A systematic review
por: Max Shah, et al.
Publicado: (2024)

Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
por: Jonathon Dawson, et al.
Publicado: (2024)

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
por: Nadia Rokan, et al.
Publicado: (2025)

Validation of the diagnostic accuracy of a urine‐based DNA methylation marker test in patients with upper urinary tract lesions
por: Christian Daniel Fankhauser, et al.
Publicado: (2026)

Treatment outcomes of multidisciplinary management of recurrent urinary tract infections: A 2‐year experience in a dedicated complex‐UTI clinic
por: Pragnitha Chitteti, et al.
Publicado: (2026)

Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
por: Maxwell Louis Sandberg, et al.
Publicado: (2026)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
por: Eric Margolis, et al.
Publicado: (2025)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
por: Esther H. J. Hamoen, et al.
Publicado: (2025)

The carbon footprint of transperineal prostate biopsy
por: Daniel A. Carson, et al.
Publicado: (2025)

Assessing EAU criteria for high‐risk upper tract urothelial carcinoma
por: Mahmoud Farzat, et al.
Publicado: (2025)

Emerging tools for the early detection of prostate cancer
por: Muhammad Haider, et al.
Publicado: (2025)

In silico tools for mechanical analysis of extra‐ and intra‐luminal artificial urinary sphincters
por: Gianluca Mazzucco, et al.
Publicado: (2024)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
por: Sophia M. Abusamra, et al.
Publicado: (2025)

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
por: Abel Tesfai, et al.
Publicado: (2024)

Male stress urinary incontinence surgery in Australia: Temporal trends over two decades
por: Omattage Mahasha Perera, et al.
Publicado: (2026)

Bibliometric analysis of focal therapy in prostate cancer research
por: Mohammed Shahait, et al.
Publicado: (2024)

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
por: Ryan Sutherland, et al.
Publicado: (2024)

Day‐case artificial urinary sphincter for post‐prostatectomy incontinence: A comparative pilot study
por: Konstantinos Kapriniotis, et al.
Publicado: (2024)

Outcome of post‐prostatectomy stress urinary incontinence surgery in men with preoperative idiopathic detrusor overactivity
por: Nikita R. Bhatt, et al.
Publicado: (2024)

Robot‐assisted laparoscopic continent cutaneous urinary diversion in adults: A single‐centre study
por: Thomas Loubersac, et al.
Publicado: (2024)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
por: Ailene E. Corona, et al.
Publicado: (2026)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
por: Eric V. Li, et al.
Publicado: (2024)

National survey of urologists' views on prostate cancer screening in the United Kingdom
por: Nikhil Mayor, et al.
Publicado: (2026)

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
por: Ruth Pidsley, et al.
Publicado: (2024)

Cumulative incidence and risk factors for recurrence of upper tract urothelial carcinoma in patients undergoing radical cystectomy
por: Ryo Yamashita, et al.
Publicado: (2024)

Waiting time in diagnosis and extirpative surgery and association with survival and stage progression in upper tract urothelial carcinomas
por: Fredrik Liedberg, et al.
Publicado: (2025)

The significant costs of prostate cancer management—An analysis from a Caribbean hospital
por: Geneva Pantoja, et al.
Publicado: (2025)

Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
por: Sofia Mesquita, et al.
Publicado: (2025)

Evaluating the utility of the HAS‐BLED bleeding‐estimator tool for transurethral resection of prostate
por: Lu Yu Kuo, et al.
Publicado: (2025)

Risk factors of negative prostate biopsies: A CHAID decision tree analysis
por: Pierre Allainguillaume, et al.
Publicado: (2026)

Preoperative pelvic floor muscle diameter as a predictor of postoperative urinary incontinence in robotic‐assisted laparoscopic total prostatectomy
por: Sho Hashimoto, et al.
Publicado: (2025)

Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
por: Jeremy Cheng, et al.
Publicado: (2025)

Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
por: Samantha Shekar, et al.
Publicado: (2025)

A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
por: Marcus Sondermann, et al.
Publicado: (2025)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
por: Arjun Pon Avudaiappan, et al.
Publicado: (2024)